Shanghai Henlius Biotech, Inc. (2696.HK) HKSE
58.65
-4.6(-7.27%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 28.07B |
| Enterprise Value | 30.89B |
| P/E Ratio | 33.84 |
| PEG Ratio | 0.34 |
| Price/Sales Ratio | 4.12 |
| Price/Book Ratio | 7.07 |
| Enterprise/Revenue | 4.55 |
| Enterprise/EBITDA | 27.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.24 |
Income Statement
| Revenue | 6.67B |
| Revenue/Share | 12.05 |
| Gross Profit | 4.98B |
| EBITDA | 1.16B |
| Net Income | 805.64M |
| Diluted EPS | 1.47 |
Balance Sheet
| Total Cash | 772.21M |
| Total Cash/Share | 1.4 |
| Total Debt | 3.6B |
| Total Debt/Equity | 0.91 |
| Current Ratio | 0.71 |
| Book Value Per Share | 7.16 |
Price History
| 52-Week Change | 26.67 |
| 52-Week High | 92 |
| 52-Week Low | 43.8 |
| Moving Average 50 Days | 74.16 |
| Moving Average 200 Days | 70.04 |
Statistics
| Average Volume | 954,954 |
| Shares Outstanding | 543.49M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
